Lou Kettering | U. Pittsburgh School of Law, US
FEBRUARY 12, 2023
A coalition of 22 states Friday filed an amicus brief opposing a proposed preliminary injunction that would withdraw or suspend the US Food and Drug Administration’s (FDA) approval of the abortion medications Mifepristone and Mifeprex. The case is in the US District Court for the Northern District of Texas Amarillo Division.
The brief asserts that the medications are safe and effective. Additionally, the brief claims that the drugs help promote access to abortion in rural and underserved communities. The brief states that withdrawing the FDA’s approval of the drugs risks undermining “the integrity of the FDA-approval process for other drugs.”